Skip to main content
Premium Trial:

Request an Annual Quote

Aushon Biosystems Expands into Chinese Market with LightArray Partnership


By Justin Petrone

Aushon BioSystems has partnered with LightArray Biotech to provide Aushon's suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions in China, the Billerica, Mass.-based firm said this week.

Based in Shanghai, LightArray operates a drug development services laboratory in nearby Wuxi, and will now provide local researchers with protein biomarker testing based on Aushon's protein biomarker platforms.

According to Aushon, its menu includes more than 300 validated arrays, a multiplex biomarker sample testing service, protein biomarker kits, custom array and assay development, and array imaging and analysis systems.

Aushon CEO Pete Honkanen in a statement called the partnership with LightArray "strategic" and said it "enables companies located in China and involved in pre-clinical and clinical research to take advantage" of the firm's products and services.

LightArray CEO Alan Zhang said in a statement that the "adoption of biomarkers as a critical research tool in preclinical and clinical studies is growing rapidly in China," and LightArray's ability to provide regional access to Aushon's products and services will be "vital."

Financial details were not discussed.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.